Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | +100.00% | -50.00% |
2023 | Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 | CI |
2023 | Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 | CI |
Financials (USD)
Sales 2021 | 0.2 | Sales 2022 | 0.28 | Capitalization | 1.35M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | -2M | EV / Sales 2021 | 79,967,019 x |
Net Debt 2021 | 2.71M | Net Debt 2022 | 4.06M | EV / Sales 2022 | 19,023,098 x |
P/E ratio 2021 |
-1.39
x | P/E ratio 2022 |
-0.2
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.01% |
1 day | +100.00% | ||
1 week | +100.00% | ||
Current month | -33.33% | ||
1 month | -33.33% | ||
3 months | -71.43% | ||
6 months | -80.00% | ||
Current year | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 55 | 15-05-31 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 15-04-20 |
Rick Panicucci
BRD | Director/Board Member | 63 | 18-02-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.0002 | +100.00% | 1,123 |
24-04-16 | 0.0001 | +9,900.00% | 500 |
Delayed Quote OTC Markets, April 18, 2024 at 02:32 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.00% | 29.02K | |
-2.20% | 104B | |
+1.49% | 97.42B | |
+0.79% | 22.2B | |
-18.06% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.16% | 15.06B | |
+4.14% | 13.98B | |
+34.74% | 11.66B |
- Stock Market
- Equities
- QBIO Stock